Begin submission
The submission of abstracts started on Sep 1, 2009 and is closed now since the deadline has passed.
Deadlines
November 20, 2009 Submission deadline of abstracts
November / December, 2009 Notification of authors about acceptance of their papers
Objectives
To provide the latest data on diagnosis, care, prevention of complications and the disease itself in different populations. This include and is not limited to present all facts but also stakeholders perspective involved in the field. In addition of bringing people together who are active and interested in the prevention of diabetes and its complication world wide we develop an environment where they can meet and exchange experiences, discussing together ideas and challenges based on their daily work.
Aim of the Congress
To provide the most complete panorama for a discussion looking to obtain what in real world is needed to enable efficient strategies and tools for better diabetes diagnosis, treatment and prevention at all levels.
Topics
- Prevention of type 1 diabetes
- Primary prevention of type 1 diabetes
- LADA and Double Diabetes
- Prevention of Type 1 diabetes in practice
- Diet and lifestyle rules for subjects at risk of type 1 diabetes – Approach to adults
- Diet and lifestyle rules for subjects at risk of type 1 diabetes – Approach to children and their family
- Ongoing trials in children and adults with recent-onset type 1 diabetes
- β cells in diabetes prevention
- Protection of ß-cell function in type 1 diabetes
- β cell preservation strategies in type 2 diabetes
- Trials on improvement of beta cell activity and insulin resistance using interventions for primary prevention
- Diabetes prevention genetics
- Genetotyping or phenotyping for people at risk of diabetes?
- Monogenetic Diabetes
- Gene-lifestyle interaction in diabetes prevention
- Why gene variants predict type 2 diabetes?
- Genetics and screening
- Genetotyping or phenotyphing for people at risk of diabetes
- Monogenetic diabetes
- Biomarkers in diabetes prevention
- IFG and IGT – similarities and differences
- Vascular risk assessments
- New markers vs. Course
- Role of hemoglobin A1c estimations and risk score questionaries in screening and predicting type 2 diabetes
- Other screening markers
- Diabetes prevention practice – scientific aspects
- Metabolic memory and prevention – relevant for clinical practice?
- Diabetes and depression
- Nutrition in diabetes prevention
- Nutrigenomics
- Importance of GI/GL in diabetes prevention
- Detecting diabetes risk in different settings
- Strategies and experiences how to set us a prevention program
- Sociocultural conditions and diabetes pandemic
- e-health in diabetes prevention
- e-health based information campaigns
- Electronic intervention programmes
- Electronic disease registries
- e-health education
- Environmental factors affecting diabetes prevention
- Media and diabetes prevention
- City planning aspects
- Poverty and diabetes (health) promotion and diabetes prevention
- Target population in diabetes prevention
- Prevention of type 2 diabetes in childhood and adolescence
- Prevention of type 2 diabetes in adults
- Gestational Diabetes
- Business planning in diabetes prevention
- Individual Praxis level
- Institution/Organization level
- Economic costs of diabetes
- Successful diabetes prevention team
- Incentive in prevention – “Pay for Performance”
- Training
- Motivation within the diabetes prevention team
- Who are the members of the “Perfect team” in diabetes prevention?
- Policy making in diabetes prevention
- Stakeholder involvement
- Food policy and diabetes (health) promotion and diabetes prevention
- Politic unification issues
- Implementation of African Declaration of Diabetes – what has been achieved?
- Consensus on targets of glycaemia control
- Political support – a prerequisite for the protecting public health
- Barriers in (diabetes) prevention
- Behavioural barriers
- Challenges in prevention
- How to maintain life style changes
- Can type 2 diabetes be cured?
- Challenges in managing diabetes in middle income countries
- Global epidemiology of type 2 diabetes
- Challenges of prevention and management of diabetes in resource poor countries
- Obesity emerging
- Prevention in the 3rd world
- Rapid increase of type 2 diabetes vs. low incidence of type 1 diabetes in Asian countries
- How to keep motivation
- Occupational healthcare – Diabetes prevention at work
- Diabetes prevention practice
- Quality management: how to improve “compliance”
- Intervention programmes
- Risk stratification
- Settings
- Challenges
- Involvement of a multidisciplinary team “in action”
- Failures – What have you done that is not working?
- National prevention programmes
- Africa
- America
- Asia & Pacific Islands
- Europe
- Prevention of diabetes complications
- Do the new insulin analogues make a difference?
- Does blood glucose lowering prevent cardiovascular disease?
- ESC/EASD guidelines in Cardiodiabetology – Where are we in implementation?
- Drugs in diabetes prevention
- Diabetes as adverse event of drug treatment
- Disease management in diabetes – the right place for prevention
- Diabetes prevention as part of disease management
- Differentiation between primary and secondary prevention
- Preventing chronic disease – opportunities for merged professional initiatives?
- Diabetes and CVD: Common soil for Metabolic Syndrome?
- Common links in diabetes and heart failure prevention
- Customizing assessment of total cardiovascular risk
- Prevention of type 2 diabetes
- Policy development
- Gestational diabetes
- Physical activity aspects
- Minority and ethnics aspects in diabetes prevention
- Diabetes prevention worldwide
- Networking in diabetes prevention
- Products in diabetes prevention